Dr. Richard Griesbach

Areas of activity

Generation of stable cell lines for pharmaceutical target validation. Application of third generation lentiviral expression systems. Further development of cell culture models for inflammatory and immunological research. 

stages of career

from 2013 Scientific assistant in the working group Target Expression Systems

2012-2013 Post-Doc at Helmholtz Zentrum München, Department of Cellular Signal Integration

2008-2012 PhD at Helmholtz Zentrum München on basic mechanisms of T cell activation

2007-2008 Diploma thesis on changes in gene expression profile in phenotypic modulation of smooth muscle cells

2002-2007 Study of Biochemistry at the Eberhard-Karls-University Tübingen and the Ludwig-Maximilian-University Munich

Dr. Richard Griesbach

Scientist Molecular neurobiology
T +49 (0)7121 51530-74
F +49 (0)7121 51530-62


  • Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells
    Meininger I, Griesbach RA, Hu D, Gehring T, Seeholzer T, Bertossi A, Kranich J, Oeckinghaus A, Eitelhuber AC, Greczmiel U, Gewies A, Schmidt-Supprian M, Ruland J, Brocker T, Heissmeyer V, Heyd F, Krappmann D
    Nat Commun. 2016 Apr 12;7:11292. doi: 10.1038/ncomms11292.